We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » WHO Hits Cadila Over Data Integrity Issues, GMP Violations
WHO Hits Cadila Over Data Integrity Issues, GMP Violations
Shortly after receiving an FDA warning letter for major quality deficiencies, Indian drugmaker was slammed for data integrity issues and GMP violations by the World Health Organization.